UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005568
Receipt number R000006147
Scientific Title A randomized phase II study of efficacy of risendronate for the prevention of letrozole-induced bone mineral loss in post-menopausal breast cancer patients
Date of disclosure of the study information 2011/05/07
Last modified on 2020/03/13 00:06:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized phase II study of efficacy of risendronate for the prevention of letrozole-induced bone mineral loss in post-menopausal breast cancer patients

Acronym

Hiroshima FEmare with Actonel Trial(H-FEAT)

Scientific Title

A randomized phase II study of efficacy of risendronate for the prevention of letrozole-induced bone mineral loss in post-menopausal breast cancer patients

Scientific Title:Acronym

Hiroshima FEmare with Actonel Trial(H-FEAT)

Region

Japan


Condition

Condition

breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of risendronate for the prevention of letrozole-induced bone mineral loss in post-menopausal breast cancer patients

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

rate of change from baseline to 12 months in lumbar spine (L1-L4) bone mineral density

Key secondary outcomes

rate of change from baseline to 6 months in lumbar spine (L1-L4) bone mineral density
rate of change from baseline to 12 months in total hip bone mineral density
rate of change from baseline to 12 months in bone turnover markers


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

period: 12months
risedronate: 17.5mg/week
letrozole: 2.5mg/day

Interventions/Control_2

period: 12months
letrozole: 2.5mg/day

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Postmenopausal women with hormonereceptor-positive early invasive breast cancer
Patient who completed surgery, chemotherapy and radiotherapy as primary therapy within recent 12 weeks
Eligible for letrozole as adjuvant therapy
T-score is greater than -2.5 in lumbar spine (L1-L4)
Patient who have no fracture in lumber spine and hip
Patient who is not administered any medication that alter bone mineral density
Proved to be eligible for administration of risedronate after consultation of dentistry
Adequate general condition
ECOG PS 0-2
Provided written Informed consent

Key exclusion criteria

Metastatic breast cancer
Patient who have lumber spine or hip fracture
Previous history of endocrine therapy for breast cancer within recent 12 months
Patient who is not suitable condition for measurement of bone mineral density
Patient who is planned to undergo dentistry surgery within 6 weeks
Contraindication of study drugs

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Morihito
Middle name
Last name Okada

Organization

Hiroshima University Hospital

Division name

Respiratory Surgery

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima

TEL

082-257-5869

Email

morihito@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Shinsuke
Middle name
Last name Sasada

Organization

Hiroshima University Hospital

Division name

Breast Surgery

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima

TEL

082-257-5869

Homepage URL

http://home.hiroshima-u.ac.jp/genge/

Email

shsasada@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

Hiroshima University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Center for Integrated Medical Research, Hiroshima University

Address

1-2-3 Kasumi, Minami-ku, Hiroshima

Tel

082-257-1752

Email

protocol@cimr.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

広島大学病院(広島県)、県立広島病院(広島県)、広島総合病院(広島県)


Other administrative information

Date of disclosure of the study information

2011 Year 05 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 05 Month 06 Day

Date of IRB

2011 Year 05 Month 06 Day

Anticipated trial start date

2011 Year 05 Month 01 Day

Last follow-up date

2015 Year 03 Month 01 Day

Date of closure to data entry

2015 Year 06 Month 01 Day

Date trial data considered complete

2015 Year 09 Month 01 Day

Date analysis concluded

2015 Year 09 Month 01 Day


Other

Other related information



Management information

Registered date

2011 Year 05 Month 07 Day

Last modified on

2020 Year 03 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006147


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name